MARK GLOTKOWSKI: Open Payments
NPI 1821398660 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,826 in 39 payments from 9 companies in 2025. Trend: 2023 $579 · 2024 $606 · 2025 $7,826
Consulting: $6,000Food & beverage: $923Travel & lodging: $865Education: $39
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $7,235 |
| Lundbeck LLC | 11 | $189 |
| Alkermes, Inc. | 1 | $120 |
| Neurocrine BioSciences, Inc. | 5 | $104 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
| ABBVIE INC. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: REXULTI, LYBALVI, INGREZZA, COBENFY, INVEGA SUSTENNA, VRAYLAR, FANAPT, UZEDY.
Industry payments across MI — which companies pay providers there.
